Gainers Alector (NASDAQ:ALEC) shares increased by 9.7% to $2.59 during Tuesday's after-market s

Gainers AIxCrypto Hldgs (NASDAQ:AIXC) stock increased by 132.0% to $1.65 during Tuesday's regul

Gainers Amylyx Pharmaceuticals (NASDAQ:AMLX) stock increased by 27.5% to $27.32 during Tuesday'

DocGo NASDAQ: DCGO reported second-quarter revenue of $73.4 million, down from $80.4 million a year

DocGo Inc. (DCGO) Q2 2026 Earnings Call Transcript

DocGo Inc. (DCGO) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus E

DocGo (NASDAQ:DCGO) reported second-quarter financial results on Monday. The transcript from the com

Gainers INVO Fertility (NASDAQ:IVF) stock moved upwards by 13.1% to $1.73 during Monday's after

DocGo (NASDAQ:DCGO) narrows FY2026 sales outlook from $300.000 million-$315.000 million to $305.000

DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.16) per share which missed the analyst consensu

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider

DocGo Inc. (NASDAQ:DCGO) will release its second earnings report after the closing bell on Monday, A

DocGo Inc. (DCGO) to report Q2 earnings on Aug. 17. Expected loss of 15 cents/share. Raised FY sales

Gainers BioVie (NASDAQ:BIVI) shares increased by 39.4% to $1.77 during Wednesday's regular sess

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob

DocGo Inc. (DCGO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabl

In conjunction with this launch, PTI Health has expanded its relationship with a major national clin

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider

DocGo NASDAQ: DCGO Chief Executive Officer Lee Bienstock outlined the company's transition away from

DocGo Inc. (DCGO) Q1 2026 Earnings Call Transcript

DocGo NASDAQ: DCGO reported first-quarter revenue of $75.6 million and an adjusted EBITDA loss of $1

DocGo Inc. (DCGO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estim

DocGo (NASDAQ:DCGO) raises FY2026 sales outlook from $290.000 million-$310.000 million to $300.000 m

DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.15) per share which missed the analyst consensu

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-ena

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider

Shares of DocGo Inc. (NASDAQ: DCGO - Get Free Report) have earned an average rating of "Hold" from t

DocGo (NASDAQ: DCGO - Get Free Report) and CochLear (OTCMKTS:CHEOY - Get Free Report) are both medic

Canaccord Genuity analyst Richard Close maintains DocGo (NASDAQ:DCGO) with a Hold and lowers the

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider

Stifel analyst David Grossman maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price targe

Cantor Fitzgerald analyst Sarah James reiterates DocGo (NASDAQ:DCGO) with a Overweight and mainta

DocGo (NASDAQ:DCGO) reported quarterly losses of $(1.37) per share which missed the analyst consensu

SteadyMD to Grow Clinical Staff by Up To 50% to Support Customer Base That Includes Multiple Fortune

DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.11) per share which beat the analyst consensus

DocGo (NASDAQ:DCGO) narrows FY2025 sales outlook from $300.000 million-$330.000 million to $315.000

DocGo Inc. (Nasdaq: DCGO) ("DocGo" or the "Company"), a leading provider of technolo

Strategic Acquisition Combines DocGo's Last Mile Healthcare Delivery Capabilities With SteadyMD&